1.An ELISA Assay to Detect IgM and IgA Anti-LSP
Chinese Journal of Immunology 1985;0(03):-
An indirect ELISA to detect IgM and IgA autoantibodies against liver-specific membrane lipoprotein(anti-LSP)in human sera is described. Human LSP was used as the coated antigen. Serum samples were pre-absorbed by SPA(bacteria)reagent. The results of serial identifications and the detection of 182 patiens with viral hepatitis indicated this procedure was specific, its duplicate was satisfactory, and the method could be valuable for iurther studying the role of anti-LSP in the pathogenesis of viral hepatitis. Key words: ELISA, Liver-specific membrane lipoprotein, Viral hepatitis, IgM, IgA.
2.Percutaneous vertebral augmentation with the Vessel-X bone void filling container system: A preliminary clinical trial
Zhaomin ZHENG ; Guanming KUANG ; Zhiyong DONG
Chinese Journal of Minimally Invasive Surgery 2001;0(02):-
Objective To explore the clinical effectiveness and safety of percutaneous vertebral augmentation with the Vessel-X bone void filling container system (Vesselplasty). Methods Three cases of fresh osteoporotic vertebral compression fracture were treated with Vesselplasty. After procedure, the pain relief, the fracture reduction, and the cement distribution in the vertebra were observed. Results All the 3 cases were treated with the unipediclar injection technique. The operative time was 45, 32 and 30 min, respectively. The hemorrhage volume was
3.Levels of Various Anti-nuclear Component Antibodies in Patients with SLE are not Correlated with the Disease Activity
Liwei JIN ; Zhiyong LU ; Jie ZHENG
Chinese Journal of Dermatology 2003;0(09):-
Objective To investigate the correlation between the disease activity and the serum levels of anti-nuclear autoantibodies against various nuclear components in the patients with systemic lupus erythematosus (SLE). Methods Two hundred and twenty five SLE patients enrolled from 2000 to 2002 were evaluated retrospectively. All patients fulfilled the ACR 1997 diagnostic criteria for SLE. The patients were divided into three groups according to the disease activity: mild group (Group A), moderate group (Group B)and severe group (Group C), as assessed with SLEDAI score. These cases were also divided into 2 groups according to the serum levels of anti-dsDNA antibody. 52 out of 225 patients were followed up further. Results ①There was no correlation between the serum level of anti-dsDNA antibody and SLEDAI score, and between the serum level of ANA and SLEDAI score in 225 patients. ②The serum level of anti-dsDNA antibody in group C was higher than that in group A or group B (P 0.05). Conclusions A positive correlation between the anti-dsDNA antibody and the disease activity was found in the severe group of SLE, but not found in the mild or moderate group. Although the renal damage was more commonly seen in those with higher level of anti-dsDNA antibody, but there is no correlation between the level of anti-dsDNA antibody and the degree of renal lesion.
4.Liver transplantation for 23 patients with hepatocellular carcinoma
Tingbo LIANG ; Zhiyong YU ; Shusen ZHENG
Chinese Journal of General Surgery 2001;0(09):-
Objective To evaluate liver transplantation for patients with hepatocellular carcinoma (HCC).Methods From Feb,1999 to Mar,2002 a total of 95 cases underwent liver transplantation(LTX) in our centre, among them there were 23 cases of HCC.SPSS 10 0 software was used to evaluate the risk factors on the tumor recurrence after LTX.Results The tumor recurrence rate was 65% during the period of follow up. The patients' tumor free survival rate at 6 and 12 months was 75 0% and 58 3%, respectively. Multi variants analysis revealed that there was a statistical relationship between pretransplant tumor size and tumor recurrence( P =0 024).Statistical relations between preoperative demograplaic, clinical features and post LTX recurrence were not found.Conclusion Large hepatocellular carcinoma is a relative contraindication for LTX.
5.The release of polyamines and excitatory amino acid during cerebral ischemia and reperfusion
Caimei ZHENG ; Honghua LI ; Zhiyong LU
Journal of Third Military Medical University 1983;0(04):-
The dynamic changes of the contents of polyamines and excitatory amino acid in the hippocampus during cerebral ischemia and reperfusion were observed in rats.It was found that the content of putrescine was increased and the release of excitatory amino acid elevated during reperfusion,and the increase of putrescine could be stopped when the antagonist of NM-DA receptor of excitatory amino acid,that is,MK-801,was administered.These facts suggest that the metabolic disturbance of polyamines in closely related to the release of excitatory amino acid and modulated by NMDA receptors.The combination of polyamines with excitatory amino acid may play an important role in the ischemic damage of the brain.
6.Immunohistochemical study of endothelin in early acute myocardial ischemia in rats
Zhiyong WANG ; Zheng LI ; Xinshan CHEN ;
Chinese Journal of Forensic Medicine 1988;0(04):-
Objective Study the expression of endothelin(ET) of ischaemic myocardium in rat. Method Sixty Wistar rats were randomly divided into 5 groups: coronary artery simply-ligated group,drug-pre-treated group(Isoproterenol,Pituitrin),coronary atherosclerotic group,sham-operated group(as control group). The samples were cut at 15min,30min,45min,60min,90min,120min after coronary (left anterior descending) ligation, and stained with HE and strept avidin-biotin enzyme complex(SABC)method. Results The expression of endothelin was observed with light microscope. Ischaemic myocardium showed ET-positive staining at the early stage of acute myocardial ischaemia in different groups and more in the pre-treated group. Conclusion the SABC-ET method may provide a new marker for diagnosing early myocardial ischaemia, which will be helpful in confirming the cause of sudden coronary death(SCD).
7.Comparison of clinieul efficacy between video-assisted mini-thoracotomy and routine open thoracotomy in treatment for carcinoma of esophagus
Chunpeng ZHENG ; Junhui FU ; Zhiyong WU ; Haibo ZHENG
Chinese Journal of Primary Medicine and Pharmacy 2009;16(8):1418-1419
Objective To evaluate the advantage of video-assisted mini thoracotomy for patients with esophageal cancer compared with routine open thomcotomy.Methods Perioperative clinical results were compared between 24 csses received VAMT(test group)and 26 cases underwent routine open thoracotomy(control group)during the same period.All the cancer stages were T2-3N0-1M0.Results This study showed that VAMT Was a minimally invasive swgew with shorter operation time(40.0±3.3)min vs.(70.3±3.2)min,P<0.05)and had less bleeding volume both during and after operation compared to the control group(108.1±15.2)ml V8.(200.1±11.3)ml,(380.8±45.4)ml vs.(780.1±52.2)ml,P<0.05).No significant differences were observed in the two groups with respect to complication occurrence rate(4.2%vs.19.2%,P>0.05).Conclusion It is suggested that VAMT is safe,reliable and less invasive in the treatmem of esophagus carcinoma.
8.Contrast analysis of the partial splenic artery embolization with splenectomy
Wusheng LU ; Qing HE ; Zhiyong ZHENG ; Shaoping WU ; Dawei XU
Journal of Interventional Radiology 2006;0(07):-
Objective To analyze the effects and the complications of partial splenic artery embolization(PSE)and splenectomy offering a feasible way to choose different therapeutic methods for hypersplenism. Methods Forty-six patients treated with PSE and thirty-three undergone splenectomy were compared for their effectivenesses and complications in treating hypersplenism. Results Thrombocyte and leucocyte counts increased markedly after the two kinds of treatment(P 0.05). The complication rate of the PSE was far more than that of the splenectomy(P
9.Hepatic intraarterial~(131)Ⅰ-HAb18F(ab')_2 radioimmunotherapy on PLC with different types of blood supply through DSA
Shaoping WU ; Wusheng LU ; Dawei XU ; Zhiyong ZHENG
Journal of Interventional Radiology 1994;0(04):-
Objective To study the possible different effects on primary liver cancer of various types of blood supply demonstrated by DSA via hepatic artery radioimmunotherapy with 131Ⅰ-HAb18F(ab')2.Methods Under thyroid protection and negative dermal sensitivity test,46 times of intraarterial injection with a 0.75 mCi/kg dose of 131Ⅰ labeled murine HCC monoclonal antibody fragment [HAb18F(ab')2] were performed in 30 patients of PLC using the Seldinger technique.The shrinkage rates of tumor volume were analyzed according to hyper,moderate and hypo vascular three types provided by DSA.Results The volume shrinkage rates of hyper and moderate vascular HCC were 60% and 37.5% respectively,while that of 2 cases of hypovascular HCC showed significantly reduction.Conclusion 131Ⅰ-HAb18F(ab')2 internal radioimmunotherapy prossesses certain signification volume shrinkage efficacy on different blood supplies provided by DSA.(J Intervent Radiol,2007,16:243-245)
10.Effect of hepatic intraarterial ~(131)I-HAb18F(ab')2 radioimmunotherapy in primary liver cancer with portal vein tumor thrombus
Shaoping WU ; Wusheng LU ; Dawei XU ; Zhiyong ZHENG
Journal of Interventional Radiology 2006;0(08):-
Objective To analyze the clinical effects of 131I-HAb18F(ab')2 radioimmunotherapy via hepatic artery on PLC with portal vein tumor emboli. Methods Under the condition of thyroid protection and negative dermal sensitivity test, 12 times of intraarterial injection with 131I labeled murine HCC monoclonal antibody fragment HAb18F(ab')2 were performed in 8 patients of PLC complicated with portal vein tumor emboli. A 0.75 mCi/kg dose of 131I was administrated individually into certain target vessel after hepatic artery angiography using Seldinger technique. Results 3 of 7 patients with symptoms of pains showed remission with simultaneous improvement and stabilization in Karnofsky score in 3 and 4 patients respectively. AFP levels decreased about 50%(3/6)in 3 cases among those 6 positives and the values of I.B. and ALT changed within a very narrow range to a certain extent after the treatment. The overall rate of CR + PR was 28.6% and similar better result was obtained in a non-symptomatic diffuse PLC patient.1 year survival rate was 12.5%. Conclusion 131I-HAb18F(ab')2 radioimmunotreating drug(0.75 mCi/kg)with hypotoxicity to liver-function can be used as an acceptable method for unresectable PLC with portal vein tumor emboli, especially for those without tumor emboli in the main trunk.